Klaus-Peter Ossenkopp Selected Research

Acetylmuramyl-Alanyl-Isoglutamine

5/2012	Inhibition of LiCl-induced conditioning of anticipatory nausea in rats following immune system stimulation: comparing the immunogens lipopolysaccharide, muramyl dipeptide, and polyinosinic: polycytidylic acid.
1/2003	Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus-Peter Ossenkopp Research Topics

Disease

14	Nausea 12/2023 - 02/2007
6	Autism Spectrum Disorder 01/2020 - 01/2007
5	Body Weight (Weight, Body) 01/2017 - 02/2009
3	Acute-Phase Reaction 10/2018 - 05/2012
2	Infections 01/2023 - 01/2019
2	Weight Loss (Weight Reduction) 05/2012 - 01/2003
2	Breast Neoplasms (Breast Cancer) 09/2009 - 02/2009
2	Autistic Disorder (Autism) 06/2009 - 05/2008
1	Neurodevelopmental Disorders 12/2014
1	Obesity 02/2012
1	Neuroinflammatory Diseases 02/2011
1	Neoplasms (Cancer) 09/2009
1	Bacterial Infections (Bacterial Infection) 10/2007
1	Vomiting 02/2007
1	Seizures (Absence Seizure) 01/2007
1	Pain (Aches) 01/2007
1	Hyperphagia (Overeating) 05/2006

Drug/Important Bio-Agent (IBA)

10	LipopolysaccharidesIBA 01/2023 - 01/2003
9	propionic acid (potassium propionate)IBA 01/2020 - 01/2007
6	Lithium ChlorideIBA 01/2023 - 09/2011
5	EndotoxinsIBA 12/2023 - 05/2012
3	Oxytocin (Pitocin)FDA LinkGeneric 01/2023 - 12/2016
3	Volatile Fatty AcidsIBA 01/2019 - 01/2007
3	Estradiol (Delestrogen)FDA LinkGeneric 10/2018 - 02/2009
2	SaccharinIBA 06/2012 - 09/2011
2	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2012 - 01/2003
2	SolutionsIBA 09/2011 - 05/2006
2	Estrogen ReceptorsIBA 09/2009 - 02/2009
2	Selective Estrogen Receptor Modulators (SERM)IBA 09/2009 - 02/2009
2	Tamoxifen FDA LinkGeneric 09/2009 - 02/2009
1	EmeticsIBA 10/2021
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2019
1	Poly I-CIBA 05/2012
1	CorticosteroneIBA 06/2011
1	Gastrointestinal AgentsIBA 02/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 02/2009
1	Dopamine (Intropin)FDA LinkGeneric 10/2007
1	CannabinoidsIBA 02/2007
1	anandamide (arachidonylethanolamide)IBA 02/2007
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 02/2007
1	LithiumIBA 02/2007
1	Sucrose (Saccharose)IBA 05/2006
1	Pregnanolone (Allopregnanolone)IBA 05/2006

Therapy/Procedure

3	Injections 01/2017 - 06/2009
2	Drug Therapy (Chemotherapy) 12/2016 - 02/2008
1	Chemoprevention 02/2009
1	Intraventricular Infusions 01/2007
1	Analgesia 01/2007